Joy Johnson
Optometrist · Nampa, IDNPI 1659324960
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,013 of the $3,279 with a category attached, or 61.4%. Alcon accounts for 64.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $1,865 and has fallen 69.0% since, to $578 in 2025.
Across 38 payments — averaging $86.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Tarsus Pharmaceuticals, Inc.$221
- Bausch & Lomb Americas Inc.$184
- Glaukos Corporation$174
- Mallinckrodt Hospital Products Inc.$122
- AbbVie$93
- plus $371 from 7 others
What the payments were for
- Travel & lodging$1,26739%
- Food & beverage$2,01361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 10 | $2,115 |
| Tarsus Pharmaceuticals, Inc. | 8 | $221 |
| Bausch & Lomb Americas Inc. | 4 | $184 |
| Glaukos Corporation | 1 | $174 |
| Mallinckrodt Hospital Products Inc. | 1 | $122 |
| AbbVie | 4 | $93 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $92 |
| Astellas Pharma US Inc | 2 | $84 |
| Johnson & Johnson Vision Care, Inc. | 1 | $79 |
| Novartis | 2 | $43 |
| ANI Pharmaceuticals, Inc. | 2 | $35 |
| Thea Pharma Inc. | 1 | $19 |
| Harrow Eye, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,279 in reported general payments places this provider in the 85th percentile of 304 optometrist providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 13 | $488 |
| ErythromycinErythromycin Base | 18 | $343 |
| Dorzolamide Hcl | 12 | $176 |
| Latanoprost | 37 | $142 |
| Brimonidine Tartrate | 13 | $118 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Nampa
- Mark McKellNampa$9K
- Rodney WhiteNampa$4K
- Jacob WatsonNampa$4K
- Scott HansenNampa$3K
- Alexandra HollingsheadNampa$3K
- Shelby StrickNampa$2K
- Drew DaytonIdaho Falls$198K
- Philip RaineyBoise$175K
- Lavar KofoedBoise$91K
- William BlackCaldwell$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.